Basic symptoms in offspring of parents with mood and psychotic disorders.

Major depressive disorder basic symptoms bipolar disorder developmental psychopathology schizophrenia

Journal

BJPsych open
ISSN: 2056-4724
Titre abrégé: BJPsych Open
Pays: England
ID NLM: 101667931

Informations de publication

Date de publication:
13 Jun 2019
Historique:
entrez: 19 9 2019
pubmed: 19 9 2019
medline: 19 9 2019
Statut: epublish

Résumé

Basic symptoms, defined as subjectively perceived disturbances in thought, perception and other essential mental processes, have been established as a predictor of psychotic disorders. However, the relationship between basic symptoms and family history of a transdiagnostic range of severe mental illness, including major depressive disorder, bipolar disorder and schizophrenia, has not been examined. We sought to test whether non-severe mood disorders and severe mood and psychotic disorders in parents is associated with increased basic symptoms in their biological offspring. We measured basic symptoms using the Schizophrenia Proneness Instrument - Child and Youth Version in 332 youth aged 8-26 years, including 93 offspring of control parents, 92 offspring of a parent with non-severe mood disorders, and 147 offspring of a parent with severe mood and psychotic disorders. We tested the relationships between parent mental illness and offspring basic symptoms in mixed-effects linear regression models. Offspring of a parent with severe mood and psychotic disorders (B = 0.69, 95% CI 0.22-1.16, P = 0.004) or illness with psychotic features (B = 0.68, 95% CI 0.09-1.27, P = 0.023) had significantly higher basic symptom scores than control offspring. Offspring of a parent with non-severe mood disorders reported intermediate levels of basic symptoms, that did not significantly differ from control offspring. Basic symptoms during childhood are a marker of familial risk of psychopathology that is related to severity and is not specific to psychotic illness. None.

Sections du résumé

BACKGROUND BACKGROUND
Basic symptoms, defined as subjectively perceived disturbances in thought, perception and other essential mental processes, have been established as a predictor of psychotic disorders. However, the relationship between basic symptoms and family history of a transdiagnostic range of severe mental illness, including major depressive disorder, bipolar disorder and schizophrenia, has not been examined.
AIMS OBJECTIVE
We sought to test whether non-severe mood disorders and severe mood and psychotic disorders in parents is associated with increased basic symptoms in their biological offspring.
METHOD METHODS
We measured basic symptoms using the Schizophrenia Proneness Instrument - Child and Youth Version in 332 youth aged 8-26 years, including 93 offspring of control parents, 92 offspring of a parent with non-severe mood disorders, and 147 offspring of a parent with severe mood and psychotic disorders. We tested the relationships between parent mental illness and offspring basic symptoms in mixed-effects linear regression models.
RESULTS RESULTS
Offspring of a parent with severe mood and psychotic disorders (B = 0.69, 95% CI 0.22-1.16, P = 0.004) or illness with psychotic features (B = 0.68, 95% CI 0.09-1.27, P = 0.023) had significantly higher basic symptom scores than control offspring. Offspring of a parent with non-severe mood disorders reported intermediate levels of basic symptoms, that did not significantly differ from control offspring.
CONCLUSIONS CONCLUSIONS
Basic symptoms during childhood are a marker of familial risk of psychopathology that is related to severity and is not specific to psychotic illness.
DECLARATION OF INTEREST BACKGROUND
None.

Identifiants

pubmed: 31530297
doi: 10.1192/bjo.2019.40
pii: S2056472419000401
pmc: PMC6582212
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e54

Références

Arch Gen Psychiatry. 2001 Feb;58(2):158-64
pubmed: 11177117
Schizophr Bull. 2009 Jan;35(1):5-8
pubmed: 19074497
Schizophr Res. 2009 Jun;111(1-3):32-8
pubmed: 19321309
Arch Gen Psychiatry. 2010 Mar;67(3):252-7
pubmed: 20194825
Depress Anxiety. 2011 Jan;28(1):50-7
pubmed: 21049533
Arch Gen Psychiatry. 2011 Apr;68(4):351-60
pubmed: 21135313
Health Econ. 2012 Jan;21(1):24-9
pubmed: 22147625
Curr Pharm Des. 2012;18(4):351-7
pubmed: 22239566
Schizophr Bull. 2012 Mar;38(2):247-57
pubmed: 22258882
Br J Psychiatry. 2012 Jul;201(1):26-32
pubmed: 22500011
JAMA Psychiatry. 2013 Jan;70(1):22-30
pubmed: 23147713
Schizophr Res. 2013 May;146(1-3):69-78
pubmed: 23473813
Psychol Med. 2014 Jan;44(2):325-36
pubmed: 23651602
Nat Genet. 2013 Sep;45(9):984-94
pubmed: 23933821
Schizophr Bull. 2014 Jan;40(1):28-38
pubmed: 23960245
Clin Psychol Sci. 2014 Mar;2(2):119-137
pubmed: 25360393
BMC Psychiatry. 2014 Dec 02;14:344
pubmed: 25439055
Eur Psychiatry. 2015 Mar;30(3):405-16
pubmed: 25735810
World Psychiatry. 2015 Jun;14(2):119-36
pubmed: 26043321
World Psychiatry. 2015 Jun;14(2):189-97
pubmed: 26043337
Lancet Psychiatry. 2014 Oct;1(5):351-9
pubmed: 26360999
Eur Child Adolesc Psychiatry. 2016 Oct;25(10):1091-102
pubmed: 26921232
World Psychiatry. 2016 Jun;15(2):118-24
pubmed: 27265696
Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):39-48
pubmed: 28054132
World Psychiatry. 2017 Feb;16(1):104-105
pubmed: 28127912
PLoS One. 2017 Feb 6;12(2):e0171595
pubmed: 28166306
World Psychiatry. 2017 Jun;16(2):200-206
pubmed: 28498576
World Psychiatry. 2017 Jun;16(2):121-129
pubmed: 28498595
Psychol Med. 2018 May;48(7):1167-1178
pubmed: 28889802
Psychol Med. 2018 Sep;48(12):1925-1936
pubmed: 29334044
Science. 2018 Feb 9;359(6376):693-697
pubmed: 29439242
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
World Psychiatry. 2018 Jun;17(2):149-160
pubmed: 29856543
Transl Psychiatry. 2018 Oct 2;8(1):205
pubmed: 30279410
Eur Arch Psychiatry Clin Neurosci. 2018 Oct 25;:null
pubmed: 30361925
Arch Gen Psychiatry. 1978 Jul;35(7):837-44
pubmed: 678037
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677

Auteurs

Alyson Zwicker (A)

Nova Scotia Health Authority; and Department of Pathology, Dalhousie University, Canada.

Lynn E MacKenzie (LE)

Nova Scotia Health Authority; and Department of Psychology and Neuroscience, Dalhousie University, Canada.

Vladislav Drobinin (V)

Nova Scotia Health Authority; and Department of Medical Neuroscience, Dalhousie University, Canada.

Emily Howes Vallis (E)

Nova Scotia Health Authority; and Department of Psychiatry, Dalhousie University, Canada.

Victoria C Patterson (VC)

Nova Scotia Health Authority; and Department of Psychology and Neuroscience, Dalhousie University, Canada.

Meg Stephens (M)

Research Assistant, Nova Scotia Health Authority, Canada.

Jill Cumby (J)

Nova Scotia Health Authority, Canada.

Lukas Propper (L)

Psychiatrist, Department of Psychiatry, Dalhousie University; and IWK Health Centre, Canada.

Sabina Abidi (S)

Psychiatrist, Department of Psychiatry, Dalhousie University; and IWK Health Centre, Canada.

Alexa Bagnell (A)

Psychiatrist, Department of Psychiatry, Dalhousie University; and IWK Health Centre, Canada.

Frauke Schultze-Lutter (F)

Assistant Professor, Department of Psychiatry and Psychotherapy, Medical Faculty, Heinrich-Heine University, Germany.

Barbara Pavlova (B)

Psychologist, Nova Scotia Health Authority; and Department of Psychiatry, Dalhousie University, Canada.

Martin Alda (M)

Psychiatrist, Nova Scotia Health Authority; and Department of Psychiatry, Dalhousie University, Canada.

Rudolf Uher (R)

Psychiatrist, Nova Scotia Health Authority; Department of Pathology; Department of Psychology and Neuroscience; Department of Medical Neuroscience; Department of Psychiatry, Dalhousie University; IWK Health Centre, Canada; and Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.

Classifications MeSH